What is Capmatinib: Uses, Dosage, Side Effects and More

Capmatinib is a targeted cancer medication that specifically blocks abnormal proteins driving certain types of lung cancer growth. It's designed for people with non-small cell lung cancer that has a particular genetic change called a MET mutation, which makes cancer cells grow and spread more aggressively.

This medication represents a significant advancement in personalized cancer treatment. Rather than attacking all rapidly dividing cells like traditional chemotherapy, capmatinib works more precisely by targeting the specific molecular pathway that's fueling your cancer's growth.

What is Capmatinib Used For?

Capmatinib treats adults with advanced non-small cell lung cancer (NSCLC) that has spread to other parts of the body. Your doctor will only prescribe this medication if genetic testing shows your cancer has a specific mutation called MET exon 14 skipping.

This genetic change occurs in about 3-4% of people with lung cancer, making capmatinib a specialized treatment for a relatively small group of patients. The medication is typically prescribed when your cancer has progressed despite other treatments, or when other standard therapies aren't suitable options for your specific situation.

Your oncologist will confirm you're a candidate through tumor tissue testing or blood tests that look for this particular genetic alteration. Without this specific mutation, capmatinib won't be effective against your cancer.

How Does Capmatinib Work?

Capmatinib blocks a protein called MET that sends signals telling cancer cells to grow and spread. When this protein becomes overactive due to genetic mutations, it acts like a stuck accelerator pedal in cancer cells, making them multiply uncontrollably.

By blocking these signals, capmatinib essentially puts the brakes on cancer growth and can cause tumors to shrink. This targeted approach is considered a moderately strong cancer treatment that works differently from traditional chemotherapy.

The medication enters your bloodstream and travels throughout your body, seeking out cancer cells with the MET mutation. It's designed to be selective, meaning it primarily affects cancer cells while leaving most healthy cells relatively undisturbed.

How Should I Take Capmatinib?

Take capmatinib exactly as your doctor prescribes, typically twice daily about 12 hours apart. You can take it with or without food, but try to take it the same way each time to maintain consistent levels in your body.

Swallow the tablets whole with water - don't crush, chew, or break them. If you have trouble swallowing pills, talk to your healthcare team about strategies that might help, but never alter the tablets themselves.

It's helpful to take capmatinib at the same times each day to maintain steady medication levels. Many people find it easier to remember by linking doses to daily activities like breakfast and dinner.

How Long Should I Take Capmatinib For?

You'll typically continue taking capmatinib as long as it's working to control your cancer and you're tolerating it reasonably well. This could range from several months to years, depending on how your cancer responds and how your body handles the medication.

Your doctor will monitor your progress through regular scans and blood tests, usually every 6-8 weeks initially. If your cancer starts growing again or side effects become too difficult to manage, your healthcare team will discuss adjusting your treatment plan.

Never stop taking capmatinib suddenly or change your dose without talking to your oncologist first. Even if you're feeling well, the medication may still be actively controlling cancer growth that isn't visible or causing symptoms yet.

What Are the Side Effects of Capmatinib?

Like all cancer medications, capmatinib can cause side effects, though not everyone experiences them. Most side effects are manageable with proper support and monitoring from your healthcare team.

Understanding what to expect can help you feel more prepared and know when to reach out for help. Let's look at the different types of side effects you might experience.

Common Side Effects

These side effects occur in many people taking capmatinib, but they're usually mild to moderate and often improve as your body adjusts to the medication:

• Swelling in your hands, feet, or around your eyes (peripheral edema)
• Nausea and occasional vomiting
• Fatigue and feeling more tired than usual
• Decreased appetite
• Shortness of breath during normal activities
• Muscle and joint pain
• Diarrhea or changes in bowel habits
• Skin rash or itching

Most of these symptoms can be managed with supportive care, dietary adjustments, or additional medications. Your healthcare team will work with you to minimize their impact on your daily life.

Serious Side Effects

While less common, some side effects require immediate medical attention. Your doctor will monitor you closely for these more serious reactions:

• Severe lung problems (pneumonitis) causing persistent cough, fever, or worsening breathing
• Liver problems showing up as yellowing of skin or eyes, dark urine, or severe fatigue
• Severe swelling that doesn't improve with elevation or causes difficulty breathing
• Signs of infection like fever, chills, or persistent sore throat
• Severe skin reactions with blistering or peeling
• Heart rhythm changes causing dizziness or fainting

Contact your healthcare team immediately if you experience any of these symptoms. Early intervention can often prevent serious complications and keep you safely on treatment.

Rare But Important Side Effects

Some side effects occur infrequently but are important to recognize. These include severe allergic reactions, kidney problems, and blood clotting issues.

Your medical team will perform regular blood tests to monitor for these rare complications. While uncommon, being aware of these possibilities helps ensure prompt treatment if they occur.

Who Should Not Take Capmatinib?

Capmatinib isn't suitable for everyone, and your doctor will carefully review your medical history before prescribing it. You shouldn't take this medication if you're allergic to capmatinib or any of its ingredients.

Certain medical conditions may make capmatinib unsafe or require special monitoring. Your healthcare team will need to know about any heart problems, liver disease, kidney issues, or lung conditions you have.

If you're pregnant, planning to become pregnant, or breastfeeding, discuss this with your oncologist immediately. Capmatinib can harm developing babies, so effective contraception is essential during treatment and for several months afterward.

Capmatinib Brand Name

Capmatinib is sold under the brand name Tabrecta in the United States. This brand name helps distinguish it from other cancer medications and ensures you receive the correct prescription.

Both the generic name (capmatinib) and brand name (Tabrecta) refer to the same medication. Your pharmacy may use either name on your prescription bottle, but the active ingredient remains identical.

Capmatinib Alternatives

Currently, capmatinib is the only FDA-approved medication specifically targeting MET exon 14 skipping mutations in lung cancer. However, your doctor might consider other treatment options if capmatinib isn't suitable or stops working.

Alternative approaches might include other targeted therapies, immunotherapy medications, or traditional chemotherapy regimens. The best choice depends on your specific cancer characteristics, overall health, and treatment history.

Clinical trials investigating new MET inhibitors are ongoing, potentially offering additional options in the future. Your oncologist can discuss whether any research studies might be appropriate for your situation.

Is Capmatinib Better Than Other Lung Cancer Treatments?

Capmatinib isn't necessarily "better" than other treatments - it's specifically designed for people with MET mutations. For patients with this particular genetic change, capmatinib often works better than traditional chemotherapy.

Compared to standard chemotherapy, capmatinib typically causes fewer severe side effects and may provide better quality of life. However, it's only effective in people whose tumors have the specific MET mutation it targets.

Your doctor will consider your cancer's genetic profile, your overall health, and your personal preferences when recommending the best treatment approach. What matters most is finding the right medication for your specific situation.